Baicalein and baicalin as Zika virus inhibitors

At present, there is no effective antiviral agent for Zika virus (ZIKV), an arbovirus that is known for its teratogenic effects on newborns. Baicalein and baicalin were found to be capable of downregulating ZIKV replication up to 10 hours postinfection, while prophylactic effects were evident in pre...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Archives of virology Ročník 164; číslo 2; s. 585 - 593
Hlavní autori: Oo, Adrian, Teoh, Boon Teong, Sam, Sing Sin, Bakar, Sazaly Abu, Zandi, Keivan
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: Vienna Springer Vienna 01.02.2019
Springer Nature B.V
Predmet:
ISSN:0304-8608, 1432-8798, 1432-8798
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Popis
Shrnutí:At present, there is no effective antiviral agent for Zika virus (ZIKV), an arbovirus that is known for its teratogenic effects on newborns. Baicalein and baicalin were found to be capable of downregulating ZIKV replication up to 10 hours postinfection, while prophylactic effects were evident in pre-treated cells. Baicalein exhibited its highest potency during intracellular ZIKV replication, whereas baicalin was most effective against virus entry. Our in silico interaction assays predicted that both compounds exhibited the strongest binding affinities towards ZIKV NS5, while the virus envelope glycoprotein was the least likely target protein. These findings serve as a crucial platform for further in-depth studies to decipher the underlying anti-ZIKV mechanism(s) of each compound.
Bibliografia:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:0304-8608
1432-8798
1432-8798
DOI:10.1007/s00705-018-4083-4